Clinical Trials
64 trialsCHIPOR
UNICANCER
ProphyloCHIP
Gustave Roussy, Cancer Campus, Grand Paris
To Evaluate the Feasibility and Safety of Combining Surgery (Pancreatectomy and Cytoreduction) With HIPEC for Treating Pancreatic Cancer With Peritoneal Involvement.
Unidade Local de Saúde São João
HIPEC
Wake Forest University Health Sciences
CHIPPI
Centre Oscar Lambret
Charlie-2
Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)
KOV-HIPEC-02R
National Cancer Center, Korea
Hyperthermic Intraperitoneal Chemotherapy With Cisplatin During Surgery or Cisplatin Before Surgery for the Treatment of Stage III or IV Ovarian, Fallopian Tube or Peritoneal Cancer
Ohio State University Comprehensive Cancer Center
Treatment of Primary Peritoneal Carcinosis of Digestive Origin Using Cytoreductive Surgery and Hyperthermic Intraoperative Peritoneal Chemotherapy With Mitomycin C and Irinotecan
Hospices Civils de Lyon
PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer
City of Hope Medical Center
PERISCOPEII
The Netherlands Cancer Institute
Hyperthermic Intraperitoneal Chemotherapy for Recurrent Ovarian Cancer
Loma Linda University
TOASTIT
Mayo Clinic
An Audit of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
Tata Memorial Centre
Development and Validation of a Prediction Model for AKI Following Cisplatin-Based HIPEC in Patients With Ovarian Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
CRS/HIPEC
Mercy Medical Center
HIPEC for Peritoneal Carcinomatosis
Albert Einstein College of Medicine
GECOP-MMC
Hospital Universitario de Fuenlabrada
Heated Mitomycin and Cisplatin During Surgery in Treating Patients With Stomach or Gastroesophageal Cancer
M.D. Anderson Cancer Center
Intraperitoneal LSTA1 in CRS-HIPEC
University of California, San Diego
Secondary Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for PARP Inhibitors Resistance Patients
Fudan University
OvIP1
University Hospital, Ghent
Hyperthermic Intraoperative Intraperitoneal Chemotherapy of Recurrent Ovarian Cancer - A Feasibility Study
Cantonal Hospital of St. Gallen
HIPEC in Ovarian Carcinoma Clinical Stage IIIC and IV During Interval Laparotomy
Instituto Nacional de Cancerologia de Mexico
Intraperitoneal Chemotherapy in Gastric Cancer With Peritoneal Carcinomatosis
Instituto do Cancer do Estado de São Paulo
The Efficacy of Hyperthermic Intraperitoneal Chemotherapy to Ovarian Cancer Patients With Homologous Recombination Repair Defect and Residual: a Prospective Cohort Study
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Heated Intraperitoneal Chemotherapy in Primary Ovarian Cancer Patients
University of Kansas Medical Center
A Nomogram to Predict Major Postoperative Complications After Cytoreductive Surgery and HIPEC Based on Pre and Peroperative Criteria: Which Patient Require Intensive Monitoring?
CHU de Reims
Trial of Cytoreductive Surgery and HIPEC in Patients With Primary and Secondary Peritoneal Cancers
Holy Name Medical Center, Inc.
A Study With Intraperitoneal Cisplatin and Doxorubicin in Recurrent Ovarian Cancer and Peritoneal Carcinomatosis
Ruhr University of Bochum
Surgery With HIPEC in Treating Patients With a High Risk of Developing Colorectal Peritoneal Carcinomatosis
Zhejiang University
Hyperthermic Intraperitoneal Chemotherapy for Treatment of Relapsed Ovarian Cancer
Uppsala University Hospital
GASTRIPEC
Charite University, Berlin, Germany
Short-course HIPEC in Advanced Epithelial Ovarian Cancer
Professor Fernando Figueira Integral Medicine Institute
GUTOX
Radboud University Medical Center
Dose-dense Chemotherapy Versus Intraperitoneal Chemotherapy as First-line Chemotherapy in Advanced Ovarian Cancer
Far Eastern Memorial Hospital
Efficacy of HIPEC in Patients With Colorectal Cancer at High Risk of Peritoneal Carcinomatosis
Affiliated Cancer Hospital & Institute of Guangzhou Medical University
HIPECOV
Zhongnan Hospital
HIPEC in the Treatment of Stage IIc-IV Epithelial Ovarian Cancer After CRS (HIPECOC)
Second Affiliated Hospital, School of Medicine, Zhejiang University
HIPEC
Krankenhaus Barmherzige Schwestern Linz
Intraoperative Hyperthermic Intraperitoneal Chemotherapy With Ovarian Cancer
National Cancer Center, Korea
HIPEC in Ovarian Cancer, Case-Controls Study With 10-years Follow up
Instituto de Seguridad Social del Estado de Mexico y Municipios
EHTASEOCCS
Affiliated Cancer Hospital & Institute of Guangzhou Medical University
HIPOVA-01
Hospices Civils de Lyon
PIPACRegis
University of Magdeburg
WCC# 59 Hyperthermic Intraperitoneal Chemotherapy Utilizing Carboplatin in First Recurrence Ovarian Cancer
Masonic Cancer Center, University of Minnesota
Comparative Effectiveness of HIPEC Following Interval Debulking Surgery in Patients With Advanced-stage Ovarian Cancer
Ajou University School of Medicine
CISCA
UMC Utrecht
HIPEC/IPHC
Bay Area Gynecology Oncology
Perioperative Chemotherapy With Bevacizumab for Colorectal Carcinomatosis French Part of the Main Bev-IP Study
Hospices Civils de Lyon